Attorney General Jonathan Skrmetti Joins 50 Attorneys General Filing Motion for Preliminary Approval for $39.1 Million Settlement with Generic Drug Manufacturer Apotex over Conspiracy to Inflate Prices and Limit Competition
NASHVILLE—Tennessee Attorney General Skrmetti and a bipartisan coalition are urging consumers to check their eligibility for compensation for certain generic drug purchases as the Attorneys General seek preliminary approval for a $39.1 million settlement with generic drug manufacturer Apotex over a conspiracy to inflate prices and limit competition.
Attorney General Skrmetti and the coalition previously announced the settlement in principle with Apotex last year along with a $10 million settlement with Heritage Pharmaceuticals. At the time of that announcement, the settlement with Apotex was conditioned on the signatures of all necessary states and territories. Those signatures have been obtained, and the coalition is filing the settlement today in the U.S. District Court for the District of Connecticut in Hartford.
The settlement agreements resolve allegations that both Apotex and Heritage engaged in widespread, long-running conspiracies to artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade regarding numerous generic prescription drugs. As part of the settlement agreements, both Apotex and Heritage have agreed to cooperate in the ongoing multistate litigations against 30 corporate defendants and 25 individual executives. Both companies have further agreed to a series of internal reforms to ensure fair competition and compliance with antitrust laws.
Joining Tennessee in today’s announcement are the attorneys general of Alaska, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Northern Mariana Islands, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Utah, U.S. Virgin Islands, Vermont, Virginia, Washington, West Virginia, Wisconsin, and Wyoming.
If you purchased a generic prescription drug listed here between May 2009 and December 2019, you may be eligible for compensation. To determine your eligibility, call 1-866-290-0182 (Toll-Free), email info@AGGenericDrugs.com or visit www.AGGenericDrugs.com.
